Systemic Dosing of Thymosin Beta 4 before and after Ischemia Does Not Attenuate Global Myocardial Ischemia-Reperfusion Injury in Pigs

The use of cardiopulmonary bypass (CPB) and aortic cross-clamping causes myocardial ischemia-reperfusion injury (I-RI) and can lead to reduced postoperative cardiac function. We investigated whether this injury could be attenuated by thymosin beta 4 (TB4), a peptide which has showed cardioprotective...

詳細記述

保存先:
書誌詳細
出版年:Front Pharmacol
主要な著者: Stark, Christoffer K.-J., Tarkia, Miikka, Kentala, Rasmus, Malmberg, Markus, Vähäsilta, Tommi, Savo, Matti, Hynninen, Ville-Veikko, Helenius, Mikko, Ruohonen, Saku, Jalkanen, Juho, Taimen, Pekka, Alastalo, Tero-Pekka, Saraste, Antti, Knuuti, Juhani, Savunen, Timo, Koskenvuo, Juha
フォーマット: Artigo
言語:Inglês
出版事項: Frontiers Media S.A. 2016
主題:
Pharmacology
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4853610/
https://ncbi.nlm.nih.gov/pubmed/27199757
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2016.00115
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料